Search
for
Sort by
Research 931–960 of 1000+
- P-Phenylenediamine-Induced Angioedema-like Facies: A Case Report and Review of Pathomechanisms
- Towards cell-based therapy of alopecia areata: Autologous human Vδ2+ Foxp3+ γδTreg cells restore hair-follicle immune privilege and promote hair regrowth in human alopecia areata models ex vivo and in vivo
- Elevated serum heat shock protein-70 and interleukin-15: prognostic biomarkers correlating with clinical severity and diagnostic efficacy in active alopecia areata
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Metabolic and Vascular Inflammation in Alopecia Areata: Linking Uric Acid, Lipid Imbalance and ICAM ‐1 Upregulation
- 315 Butyrophilin-like 2 (BTNL2) controls auto-aggressive dermal γδT lymphocytes that attack human hair follicles.
- 455 Beyond Immunity: TEC and JAK3 Kinase Activation in Melanocytes Drives Inflammation in Vitiligo
- Skin γδ T cell subsets have distinct functions in alopecia areata 3844
- Is Intralesional Methotrexate an Effective Alternative to Intralesional Triamcinolone in Alopecia Areata? Findings From a Randomized Controlled Trial
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Exploring the hair follicle immune privilege state in nonsegmental vitiligo
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- 001 Human scalp hair follicles are protected from alopecia areata in vivo by regulatory γδT cells
- 499 Possible involvement of skin resident memory T cells in refractory alopecia areata
- Immunohistochemical assessment of SOX10 and its relation to the immune cellular infiltrate in alopecia areata follicles
- Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- 809 IL-13 protein concentrates in the epidermis of lesional and non-lesional skin of AD patients
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Cisd2 deficiency impairs neutrophil function by regulating calcium homeostasis via Calnexin and SERCA
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- 164 Epigenetic and transcriptional profiling of PBMCs in mild and severe alopecia areata using single-cell RNA-Seq and ATAC-Seq
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- 148 Decreased IL-10 producing regulatory B cells in patients with alopecia areata
- Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- LB708 ILC1-like innate lymphocytes in human autoimmunity: Lessons from Alopecia Areata